This will allow industry leaders to make and sell the product, in addition to providing more choice to pharma and biotech companies.
Corning Pharmaceutical Technologies announced its Velocity Vials Technology Platform on June 8, 2023 to increase access to Corning’s Velocity Vial technology. This will allow industry leaders to make and sell the product, in addition to providing more choice to pharma and biotech companies.
According to the company press release, Corning will expand its manufacturing footprint, localize its supply chains, and enable the purchase of Velocity Vials through a network of selling partners. The new partnership with Gerresheimer AG will combine Gerresheimer’s extensive glass converting expertise with Corning’s innovative external vial coating technology, which helps with co-manufacturing and selling Velocity Vials.
Shortly after, SGD Pharma joined and announced a joint venture with Corning that includes the opening of a new glass tubing facility and expanded access to Velocity Vial technology in India. Further, Velocity Vials are important to the global distribution of essential vaccines and medications during the COVID-19 pandemic, according to the company.
“We are starting to see a paradigm shift in the pharmaceutical primary-packing industry, where coated vials are becoming the new industry standard,” said Brendan Mosher, vice president and general manager, Corning Pharmaceutical Technologies, in a press release. “Velocity Vials have demonstrated immediate benefits for our customers. The adoption of the technology by leading pharmaceutical-packaging providers is yet another proof point of this evolution.”
Velocity Vials can improve filling-line efficiency by up to 50%, which lowers costs while also improving the quality. It can also reduce the likelihood of damage that leads to cracks, breaks, and cosmetic defects. The vials are made with Type 1 borosilicate glass and conform to ISO standard dimensions, and they can be dropped-in to existing operations with no significant changes or reporting to regulatory authorities, according to the company press release.
Source: Corning
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.